CFG
74
2
MUR
44
-3
URI
60
-6
DNB
74
-6
TRIP
50
-4
CRM
60
-7
GD
41
-4
MRO
50
4
MCO
71
-7
ROST
57
-3
LMT
30
-2
DHI
44
-3
TMO
42
-6
BBY
52
6
OI
42
-3
LEN
50
-2
EBAY
42
-2
HIG
66
2
OXY
36
-2
COST
57
-6
CFG
74
2
MUR
44
-3
URI
60
-6
DNB
74
-6
TRIP
50
-4
CRM
60
-7
GD
41
-4
MRO
50
4
MCO
71
-7
ROST
57
-3
LMT
30
-2
DHI
44
-3
TMO
42
-6
BBY
52
6
OI
42
-3
LEN
50
-2
EBAY
42
-2
HIG
66
2
OXY
36
-2
COST
57
-6
Financhill
Back

Biodexa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
3.55
Seasonality Move:
-24.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Biodexa Pharmaceuticals PLC Price Quote

$3.55
-0.07 (-26.95%)
(Updated: November 16, 2024 at 5:09 AM ET)

Biodexa Pharmaceuticals PLC Key Stats

Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell
Day range:
$3.51 - $4.80
52-week range:
$3.51 - $220.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.26
P/B ratio:
0.19%
Volume:
64.3K
Avg. volume:
329.5K
1-year change:
-94.35%
Market cap:
$2.1M
Revenue:
$474.1K
EPS:
$-74.6

How Much Does Biodexa Pharmaceuticals PLC Make?

Data Unavailable

Is Biodexa Pharmaceuticals PLC Growing As A Company?

Data Unavailable

Biodexa Pharmaceuticals PLC Stock Price Performance

What Is Biodexa Pharmaceuticals PLC 52-Week High & Low?

Biodexa Pharmaceuticals PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biodexa Pharmaceuticals PLC?

Is Biodexa Pharmaceuticals PLC Cash Flow Positive?

  • What Is BDRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.7M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.8M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.3M

Biodexa Pharmaceuticals PLC Return On Invested Capital

Data Unavailable

Biodexa Pharmaceuticals PLC Earnings Date & Stock Price

Biodexa Pharmaceuticals PLC Competitors

Biodexa Pharmaceuticals PLC Dividend Yield

Biodexa Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.02
Upside from Last Price: 121.41%

Major Shareholders

  • How many BDRX shares are owned by institutional investors?
    160.4K BDRX shares are owned by institutional investors
  • How many BDRX shares are owned by insiders?
    1.3M BDRX shares are owned by insiders